Literature DB >> 24803826

TNM staging of colorectal cancer should be reconsidered by T stage weighting.

Jun Li1, Bao-Cai Guo1, Li-Rong Sun1, Jian-Wei Wang1, Xian-Hua Fu1, Su-Zhan Zhang1, Graeme Poston1, Ke-Feng Ding1.   

Abstract

AIM: To verify that the T stage has greater weight than the N stage in the staging of colorectal cancer.
METHODS: Open data from the Surveillance, Epidemiology, and End Results program were reviewed and analyzed according to the T stage, N stage, and patients' observed survival (OS). The relative weights of the T and N stages were calculated by multiple linear regressions based on their impact on survival. Risk scores for 25 TN categories were then calculated from the T and N stage relative weights, and a rearranged tumor node metastasis (TNM) staging system was proposed via a cluster analysis of the TN scores.
RESULTS: Both T and N stages significantly affect the OS of patients with colorectal cancer. Moreover, the T stage has greater weight than the N stage in the TNM staging system of colorectal cancer. For colon cancer, the relative T and N stage weights were 0.58 and 0.42, respectively, and for rectal cancer, the relative T and N stage weights were 0.61 and 0.39, respectively. On the basis of cluster analysis of the TN scores, T1N1a was classified to stage I, and T2N1a-1b and T1N1b-2a were classified to stage II in our revised TNM staging system for both colon and rectal cancer. For colon cancer, T4bN0 was classified to stage IIIa, but for rectal cancer, it was classified to stage IIIb.
CONCLUSION: As the T stage affects colorectal cancer survival more significantly than the N stage, the TNM staging should be revised by relative T stage weight.

Entities:  

Keywords:  Cluster analysis; Colorectal cancer; Neoplasm staging; Observational study; Survival analysis

Mesh:

Year:  2014        PMID: 24803826      PMCID: PMC4009548          DOI: 10.3748/wjg.v20.i17.5104

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

Review 1.  The future of the TNM staging system in colorectal cancer: time for a debate?

Authors:  Philip Quirke; Geraint T Williams; Nadine Ectors; Arzu Ensari; Françoise Piard; Iris Nagtegaal
Journal:  Lancet Oncol       Date:  2007-07       Impact factor: 41.316

2.  Lymph node evaluation as a colon cancer quality measure: a national hospital report card.

Authors:  Karl Y Bilimoria; David J Bentrem; Andrew K Stewart; Mark S Talamonti; David P Winchester; Thomas R Russell; Clifford Y Ko
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

Review 3.  Overview on techniques in cluster analysis.

Authors:  Itziar Frades; Rune Matthiesen
Journal:  Methods Mol Biol       Date:  2010

4.  A comparison of the new (planned) TNM classification and Japanese general rule for staging colorectal cancer.

Authors:  Takeo Mori
Journal:  Cancer Invest       Date:  2010-05       Impact factor: 2.176

5.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08

6.  Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes.

Authors:  Leonard L Gunderson; John Milburn Jessup; Daniel J Sargent; Frederick L Greene; Andrew Stewart
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544

7.  Revised TN categorization for colon cancer based on national survival outcomes data.

Authors:  Leonard L Gunderson; John Milburn Jessup; Daniel J Sargent; Frederick L Greene; Andrew K Stewart
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544

8.  Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Authors:  Thierry André; Corrado Boni; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Andrea Bonetti; Philip Clingan; John Bridgewater; Fernando Rivera; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

9.  Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.

Authors:  Hak-Mien Quah; Joanne F Chou; Mithat Gonen; Jinru Shia; Deborah Schrag; Leonard B Saltz; Karyn A Goodman; Bruce D Minsky; W Douglas Wong; Martin R Weiser
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

10.  Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome.

Authors:  W Hohenberger; K Weber; K Matzel; T Papadopoulos; S Merkel
Journal:  Colorectal Dis       Date:  2009-11-05       Impact factor: 3.788

View more
  30 in total

1.  Surgical injury induces local and distant adipose tissue browning.

Authors:  Alban Longchamp; Ming Tao; Alexander Bartelt; Kui Ding; Lydia Lynch; Christopher Hine; Jean-Marc Corpataux; Bruce S Kristal; James R Mitchell; C Keith Ozaki
Journal:  Adipocyte       Date:  2015-11-20       Impact factor: 4.534

2.  A Novel TNM Classification for Colorectal Cancers based on the Metro-ticket Paradigm.

Authors:  Jun-Peng Pei; Chun-Dong Zhang; Xiang Fu; Yong Ba; Shuai Yue; Zhe-Ming Zhao; Dong-Qiu Dai
Journal:  J Cancer       Date:  2021-04-05       Impact factor: 4.207

3.  Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers.

Authors:  Jung Ho Kim; Jeong Mo Bae; Hyeon Jeong Oh; Hye Seung Lee; Gyeong Hoon Kang
Journal:  J Pathol Transl Med       Date:  2015-03-12

Review 4.  Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.

Authors:  A C Rogers; D C Winter; A Heeney; D Gibbons; A Lugli; G Puppa; K Sheahan
Journal:  Br J Cancer       Date:  2016-09-06       Impact factor: 7.640

5.  A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database.

Authors:  Xiangxing Kong; Jun Li; Yibo Cai; Yu Tian; Shengqiang Chi; Danyang Tong; Yeting Hu; Qi Yang; Jingsong Li; Graeme Poston; Ying Yuan; Kefeng Ding
Journal:  BMC Cancer       Date:  2018-01-08       Impact factor: 4.430

6.  The survival and clinicopathological differences between patients with stage IIIA and stage II rectal cancer: An analysis of 12,036 patients in the SEER database.

Authors:  Ben Huang; Shaobo Mo; Liang Zhu; Tianhong Xu; Guoxiang Cai
Journal:  Oncotarget       Date:  2016-11-29

7.  Combined detection of the expression of Nm23-H1 and p53 is correlated with survival rates of patients with stage II and III colorectal cancer.

Authors:  Yinying Wu; Yi Li; Xiaoai Zhao; Danfeng Dong; Chunhui Tang; Enxiao Li; Qianqian Geng
Journal:  Oncol Lett       Date:  2016-11-23       Impact factor: 2.967

8.  TNM Staging of Colorectal Cancer Should be Reconsidered According to Weighting of the T Stage: Verification Based on a 25-Year Follow-Up.

Authors:  Jun Li; Cheng-Hao Yi; Ye-Ting Hu; Jin-Song Li; Ying Yuan; Su-Zhan Zhang; Shu Zheng; Ke-Feng Ding
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

9.  Survival Contradiction Between Stage IIA and Stage IIIA Rectal Cancer: A Retrospective Study.

Authors:  Shaobo Mo; Weixing Dai; Wenqiang Xiang; Ben Huang; Yaqi Li; Yang Feng; Qingguo Li; Guoxiang Cai
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

10.  An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients.

Authors:  Yanfei Shao; Hongtao Jia; Ling Huang; Shuchun Li; Chenxing Wang; Batuer Aikemu; Guang Yang; Hiju Hong; Xiao Yang; Sen Zhang; Jing Sun; Minhua Zheng
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.